Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

Conditions: Becker Muscular Dystrophy Interventions: Drug: EDG-5506 Sponsors: Edgewise Therapeutics, Inc.; Medpace, Inc. Enrolling by invitation

Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials